Inari Medical Stock Investor Sentiment
| NARI Stock | USD 49.48 0.18 0.36% |
Under 54% of Inari Medical's investor base is interested to short. The analysis of overall sentiment of trading Inari Medical stock suggests that many investors are impartial at this time. Inari Medical's investing sentiment shows overall attitude of investors towards Inari Medical.
Inari |
Inari Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Inari Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Inari Medical that are available to investors today. That information is available publicly through Inari media outlets and privately through word of mouth or via Inari internal channels. However, regardless of the origin, that massive amount of Inari data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Inari Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Inari Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Inari Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Inari Medical alpha.
Inari Medical Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 20000 shares by William Hoffman of Inari Medical at 50.3 subject to Rule 16b-3 | 08/30/2024 |
2 | Disposition of 3000 shares by Hill, Mitch C. of Inari Medical at 0.457 subject to Rule 16b-3 | 09/12/2024 |
3 | Disposition of 7386 shares by William Hoffman of Inari Medical at 46.27 subject to Rule 16b-3 | 09/16/2024 |
4 | Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. and Encourages Investors to Contact the Firm | 09/17/2024 |
5 | Disposition of 20000 shares by William Hoffman of Inari Medical at 50.15 subject to Rule 16b-3 | 09/25/2024 |
6 | Disposition of 458 shares by Hill, Mitch C. of Inari Medical at 40.63 subject to Rule 16b-3 | 10/01/2024 |
7 | Disposition of 632 shares by Tu Thomas of Inari Medical at 40.63 subject to Rule 16b-3 | 10/03/2024 |
8 | Disposition of 12196 shares by William Hoffman of Inari Medical at 45.57 subject to Rule 16b-3 | 10/16/2024 |
9 | Inari Medical director William Hoffman sells 1.8 million in stock | 10/18/2024 |
10 | Inari Medical, Inc. Q3 2024 Earnings Call Transcript | 10/29/2024 |
11 | Inari Medical Inc Q3 2024 Earnings Revenue Hits 153M, EPS at -0. ... | 10/30/2024 |
12 | Inari Medical, Inc. CEO Sells 150,000.00 in Stock | 11/01/2024 |
13 | Inari Medical to Participate in the Jefferies London Healthcare Conference | 11/06/2024 |
14 | Insider Trading | 11/11/2024 |
15 | Disposition of 9750 shares by William Hoffman of Inari Medical at 51.16 subject to Rule 16b-3 | 11/18/2024 |
16 | Inari medical director William Hoffman sells 3.07m in stock | 11/20/2024 |
Complementary Tools for Inari Stock analysis
When running Inari Medical's price analysis, check to measure Inari Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inari Medical is operating at the current time. Most of Inari Medical's value examination focuses on studying past and present price action to predict the probability of Inari Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inari Medical's price. Additionally, you may evaluate how the addition of Inari Medical to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |